Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics

Papaluca T, Roberts SK, Strasser SI, et al. Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics. Clin Infect Dis. 2020;:ciaa1318. Online ahead if print.

Publication Type:

Journal Article

Authors:

Papaluca, T; Roberts, SK; Strasser, SI; et, al

Source:

Clin Infect Dis, p.ciaa1318. Online ahead if print (2020)

Cited On:

Export Citation:
RIS Format
Top